Urticaria: FDA reporting patterns
164,211 FDA FAERS reports mention Urticaria. 81,195 reports have a serious outcome flag.
Medicines named as suspect
- Omalizumab: 11,010 reports
- Adalimumab: 8,646 reports
- Etanercept: 8,030 reports
- Dupilumab: 6,706 reports
- Infliximab: 6,197 reports
- Acetaminophen: 5,494 reports
- Methotrexate: 5,444 reports
- Rituximab: 4,759 reports
- Tocilizumab: 4,732 reports
- Abatacept: 4,263 reports
- Cetirizine: 4,203 reports
- Leflunomide: 4,079 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.